发明名称 2-acyl indol derivatives and their use as anti-tumour agents.
摘要 The use of 2-acyl-indole derivatives (including aza analogs) (I) as antitumor agents is new. Most compounds (I) are new. The use of indole derivatives of formula (I) (including their stereoisomers, tautomers, mixtures and salts) is claimed in the preparation of medicaments for treating tumor diseases. R1 = H, alkylcarbonyl, alkyl, alkylamino-T-, dialkylamino-T- (where the dialkylamino group may form a ring, optionally containing one or more NH, N(alkyl), O or S members), arylalkyl or arylalkoxyalkyl; T = 1-4C alkyl; R2 = H, halo, CN or NO2, alkyl or alkoxy (both optionally substituted (os) by one or more halo), or alkenyl, alkynyl, cycloalkyl, alkoxy, alkoxycarbonyloxy, alkylcarbonyloxy, ST, SOT, SO2T, alkoxyalkyl, NH2, alkylamino, dialkylamino (possibly forming a ring as in R1), aryl, aryloxy, aryl-T-, aryl-T-O-T-, alkylcarbonyl, alkoxycarbonyl or OH; A1-A4 = C-R3 or N; R3 = H, halo, CN or NO2, alkyl or alkoxy (both os by one or more halo); or alkenyl, alkynyl, cycloalkyl, alkoxy, 1-6C alkylenedioxy, alkoxycarbonyloxy, alkylcarbonyloxy, ST, SOT, SO2T, COOH, alkoxycarbonyl, CONH2, CONHT, CON(T)2, alkoxyalkyl, NH2, alkylamino, dialkylamino (possibly forming a ring as in R1), aryl, aryloxy, aryl-T-, aryl-T-O-T-, alkylcarbonyl or OH, or two adjacent R3 groups may be bonded, specifically as 1-6C alkylenedioxy; Y = aryl (preferably phenyl or naphthyl), 1-13C heteroaryl (containing 1-4 of N, NH, N(alkyl), O and/or S as ring members) or cycloalkyl, all os by one or more Q; Q = halo, CN, cyanoalkyl, OH, mono- or polyhydroxyalkyl, COOH, alkoxycarbonyl, CONH2, alkylcarbamoyl, CON(T)2, NO2, alkyl or alkoxy (both os by one or more halo), alkenyl, alkynyl, cycloalkyl, SH, alkylthio, alkylsulfinyl, alkylsulfonyl, alkoxyalkyl, NH2, alkylamino, dialkylamino (possibly forming a ring as in R1), aryl, aryloxy, arylalkyl, arylalkoxyalkyl, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy, mono- or dialkylcarbonylamino, mono- or dialkoxycarbonylamino, N-alkylcarbonyl-N-alkylamino, N-alkoxycarbonyl-N-alkylamino, NHCHO or CHO; or two adjacent Q groups may be bonded, specifically as 1-6C alkylenedioxy, and X = O, S, NH or (H, OH); unless specified otherwise, alkyl moieties have 1-6C, alkenyl or alkynyl moieties 2-6C, cycloalkyl moieties 3-8C and aryl moieties 6-14C. Independent claims are included for the following: (a) new (I) (including their stereoisomers, tautomers, mixtures and salts), with the exception of (I; R1, R2 = H; A1, A3, A4 = CH; X = O or (if A2 = CH) CH(OH); Y = 3-carboxy-pyridin-4-yl; A2 = CH or C(OMe)), 2-cyclopropylcarbonyl-indole and 2-cyclohexylcarbonyl-indole; and (b) preparation of the new compounds (I).
申请公布号 ZA200209137(B) 申请公布日期 2004.06.18
申请号 ZA20020009137 申请日期 2002.11.11
申请人 BAXTER HEALTHCARE SA. 发明人 THOMAS BECKERS;SILKE BAASNER;THOMAS KLENNER;SIAVOSH MAHBOOBI;HERWIG PONGRATZ;MARKUS FRIESER;HEINZ-HERBERT FIEBIG;JOERG HOCKEMEYER;ANGELIKA BURGER;FRANK-D BOEHMER;HARALD HUFSKY
分类号 A61K31/404;A61K31/437;A61K31/4439;A61K31/4709 主分类号 A61K31/404
代理机构 代理人
主权项
地址